List of Tables:
Table 1. Snapshot of North America Drug Discovery Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. World Health Spending by Region, $ bn, 2013-2020 30
Table 5. Total Number of Registered Clinical Studies Worldwide, 2010-2019 31
Table 6. Main Product Trends and Market Opportunities in North America Drug Discovery Market 35
Table 7. North America Drug Discovery Market by Drug Type, 2019-2030, $ mn 43
Table 8. North America Drug Discovery Market by Service, 2019-2030, $ mn 47
Table 9. North America Drug Discovery Market by Process, 2019-2030, $ mn 53
Table 10. North America Drug Discovery Market by Technology, 2019-2030, $ mn 60
Table 11. North America Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 70
Table 12. North America Drug Discovery Market by End User, 2019-2030, $ mn 80
Table 13. North America Drug Discovery Market by Country, 2019-2030, $ mn 87
Table 14. U.S. Drug Discovery Market by Drug Type, 2019-2030, $ mn 91
Table 15. U.S. Drug Discovery Market by Service, 2019-2030, $ mn 91
Table 16. U.S. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 91
Table 17. Novel Drug Approvals in U.S. in 2020 92
Table 18. Canada Drug Discovery Market by Drug Type, 2019-2030, $ mn 96
Table 19. Canada Drug Discovery Market by Service, 2019-2030, $ mn 96
Table 20. Canada Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 96
Table 21. Mexico Drug Discovery Market by Drug Type, 2019-2030, $ mn 98
Table 22. Mexico Drug Discovery Market by Service, 2019-2030, $ mn 98
Table 23. Mexico Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 98
Table 24. Abbott Laboratories Inc.: Company Snapshot 103
Table 25. Abbott Laboratories Inc.: Business Segmentation 103
Table 26. Abbott Laboratories Inc.: Product Portfolio 104
Table 27. Abbott Laboratories Inc.: Revenue, 2018-2020, $ mn 104
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Drug Discovery Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Drug Discovery Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 29
Figure 9. Primary Restraints and Impact Factors of North America Drug Discovery Market 32
Figure 10. Investment Opportunity Analysis 36
Figure 11. Porters Fiver Forces Analysis of North America Drug Discovery Market 39
Figure 12. Breakdown of North America Drug Discovery Market by Drug Type, 2019-2030, % of Revenue 44
Figure 13. North America Addressable Market Cap in 2021-2030 by Drug Type, Value ($ mn) and Share (%) 44
Figure 14. North America Drug Discovery Market by Drug Type: Small Molecule Drugs, 2019-2030, $ mn 45
Figure 15. North America Drug Discovery Market by Drug Type: Biologic Drugs, 2019-2030, $ mn 46
Figure 16. Breakdown of North America Drug Discovery Market by Service, 2019-2030, % of Sales Revenue 48
Figure 17. North America Addressable Market Cap in 2021-2030 by Service, Value ($ mn) and Share (%) 48
Figure 18. North America Drug Discovery Market by Service: Medicinal Chemical Services, 2019-2030, $ mn 49
Figure 19. North America Drug Discovery Market by Service: Biological Services, 2019-2030, $ mn 50
Figure 20. North America Drug Discovery Market by Service: Drug Metabolism and Pharmacokinetics (DMPK) Services, 2019-2030, $ mn 51
Figure 21. North America Drug Discovery Market by Service: Other Pharmaceutical Services, 2019-2030, $ mn 52
Figure 22. Breakdown of North America Drug Discovery Market by Process, 2019-2030, % of Sales Revenue 54
Figure 23. North America Addressable Market Cap in 2021-2030 by Process, Value ($ mn) and Share (%) 54
Figure 24. North America Drug Discovery Market by Process: Target Selection, 2019-2030, $ mn 55
Figure 25. North America Drug Discovery Market by Process: Target Validation, 2019-2030, $ mn 56
Figure 26. North America Drug Discovery Market by Process: Hit-To-Lead Identification, 2019-2030, $ mn 57
Figure 27. North America Drug Discovery Market by Process: Lead Optimization, 2019-2030, $ mn 58
Figure 28. North America Drug Discovery Market by Process: Candidate Validation, 2019-2030, $ mn 59
Figure 29. Breakdown of North America Drug Discovery Market by Technology, 2019-2030, % of Revenue 61
Figure 30. North America Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%) 61
Figure 31. North America Drug Discovery Market by Technology: High Throughput Screening, 2019-2030, $ mn 62
Figure 32. North America Drug Discovery Market by Technology: Combinatorial Chemistry, 2019-2030, $ mn 63
Figure 33. North America Drug Discovery Market by Technology: Pharmacogenomics and Pharmacogenetics, 2019-2030, $ mn 64
Figure 34. North America Drug Discovery Market by Technology: Nanotechnology, 2019-2030, $ mn 65
Figure 35. North America Drug Discovery Market by Technology: Bioanalytical Instruments, 2019-2030, $ mn 66
Figure 36. North America Drug Discovery Market by Technology: Biochips, 2019-2030, $ mn 67
Figure 37. North America Drug Discovery Market by Technology: Bioinformatics, 2019-2030, $ mn 68
Figure 38. North America Drug Discovery Market by Technology: Other Technologies, 2019-2030, $ mn 69
Figure 39. Breakdown of North America Drug Discovery Market by Therapeutic Area, 2019-2030, % of Revenue 71
Figure 40. North America Addressable Market Cap in 2021-2030 by Therapeutic Area, Value ($ mn) and Share (%) 71
Figure 41. North America Drug Discovery Market by Therapeutic Area: Oncology, 2019-2030, $ mn 72
Figure 42. North America Drug Discovery Market by Therapeutic Area: Neurology, 2019-2030, $ mn 73
Figure 43. North America Drug Discovery Market by Therapeutic Area: Infectious and Immune System Diseases, 2019-2030, $ mn 74
Figure 44. North America Drug Discovery Market by Therapeutic Area: Digestive System Diseases, 2019-2030, $ mn 75
Figure 45. North America Drug Discovery Market by Therapeutic Area: Cardiovascular Diseases, 2019-2030, $ mn 76
Figure 46. North America Drug Discovery Market by Therapeutic Area: Diabetes, 2019-2030, $ mn 77
Figure 47. North America Drug Discovery Market by Therapeutic Area: Respiratory Disease, 2019-2030, $ mn 78
Figure 48. North America Drug Discovery Market by Therapeutic Area: Other Therapeutic Areas, 2019-2030, $ mn 79
Figure 49. Breakdown of North America Drug Discovery Market by End User, 2019-2030, % of Revenue 80
Figure 50. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 81
Figure 51. North America Drug Discovery Market by End User: Pharmaceutical Companies, 2019-2030, $ mn 82
Figure 52. North America Drug Discovery Market by End User: Contract Research Organizations (CROs), 2019-2030, $ mn 83
Figure 53. North America Drug Discovery Market by End User: Research Institutes, 2019-2030, $ mn 84
Figure 54. North America Drug Discovery Market by End User: Other End Users, 2019-2030, $ mn 85
Figure 55. Breakdown of North America Drug Discovery Market by Country, 2019 and 2030, % of Revenue 87
Figure 56. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 88
Figure 57. U.S. Drug Discovery Market, 2019-2030, $ mn 90
Figure 58. Canada Drug Discovery Market, 2019-2030, $ mn 95
Figure 59. Drug Discovery Market in Mexico, 2019-2030, $ mn 97
Figure 60. Growth Stage of North America Drug Discovery Industry over the Forecast Period 99
